Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancer

•When comparing MIS and LAP at time of HIPEC, no differences are observed in adverse perioperative outcomes.•MIS was associated with shorter hospitalization and with no significant difference in the rate of R0 resections.•Patient candidacy for an MIS IDS should not prevent surgeons from utilizing HIPEC in appropriate candidates.